Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2005
03/22/2005US6870045 Kits for detecting HIV-2
03/22/2005US6870044 Regulatory sequences for use as tool in controlling heterologous gene expression in cells
03/22/2005US6870042 Mutants of streptococcal toxin A and methods of use
03/22/2005US6870038 Isolation and expression of a gene for a nitrilase from Acidovorax facilis 72W
03/22/2005US6870033 Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies
03/22/2005US6870032 Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirus in hexameric form
03/22/2005US6870031 Haemopoietin receptor and genetic sequences encoding same
03/22/2005US6870030 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders
03/22/2005US6869936 Drug delivery via adenovirus capsids; for treatment of rheumatoid arthritis
03/22/2005US6869935 Gene Therapy for proliferative vitreoretinopathy
03/22/2005US6869933 Peptides having an amino acid sequences of the partial region of the protein from human immunodeficiency virus; cytotoxic t-cells (ctl)
03/22/2005US6869925 Comprises serine leukocyte protease inhibitor for treatment of HIV
03/22/2005US6869801 Assessment of cervical cells
03/22/2005US6869797 Method for more efficient electroporation
03/22/2005US6869795 Antisense compositions and cancer-treatment methods
03/22/2005US6869794 A packaging cell line capable of complementing recombinant adenoviruses based on serotypes from subgroup B, preferably adenovirus type 35. The cell line is preferably derived from primary, diploid human cells transformed by adenovirus E1
03/22/2005US6869793 Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccines
03/22/2005US6869791 Method for sterilizing transformed cells
03/22/2005US6869789 Heparinase III and uses thereof
03/22/2005US6869786 Method for cloning and expression of BsrGI restriction endonuclease and BsrGI methyltransferase in E. coli
03/22/2005US6869785 Cytochrome c oxidase enzyme complex
03/22/2005US6869783 Nucleic acid sequences which code for a polypeptide having nitrilase activity, nucleic acid constructs comprising the nucleic acid sequences, and vectors comprising the nucleic acid sequences or the nucleic constructs
03/22/2005US6869780 Nodavirus-like DNA expression vector and uses therefor
03/22/2005US6869779 Nucleic acid sequence for potentiating the expression of useful gene and method therefor
03/22/2005US6869777 Mini-dystrophin nucleic acid sequences
03/22/2005US6869773 Process for the manufacture of carotenoids and biologically useful materials thereof
03/22/2005US6869772 Method for labeling individual cells
03/22/2005US6869769 Utilizes at least one primer for analysis; automatic for massed screening and the discovery of sequence variants of known virons, undetected virons and others
03/22/2005US6869768 Determination genotypes
03/22/2005US6869765 Using oligonucleotides; incubating; restriction endonucleases; herpes virus origin of replication
03/22/2005US6869763 Microarray chip and method for indexing the same
03/22/2005US6869608 Peptides derived from a retrovirus of the HIV group and their use
03/22/2005US6869605 Anticarcinogenic agents
03/22/2005CA2127541C Recombinant swinepox virus
03/22/2005CA2103059C Method for making humanized antibodies
03/17/2005WO2005024428A1 Novel high throughput screening method of drug for physiologically active protein
03/17/2005WO2005024062A2 Method for the identification of attenuating lesions in pathogens
03/17/2005WO2005024061A2 Compounds and methods for modulation of dna replication
03/17/2005WO2005024059A2 Methods for identifying compounds for inhibiting fever
03/17/2005WO2005024058A2 Compounds for the treatment of diseases involving cognitive impairment, such as alzheimer’s disease, and methods for identifying such compounds
03/17/2005WO2005024057A1 Method of identifying a compound that changes the amyloid-beta precursor protein processing in a cell
03/17/2005WO2005024044A2 Method for the production of fusion proteins in transgenic mammal milk
03/17/2005WO2005024042A2 Aptamers and methods for their in vitro selection and uses thereof
03/17/2005WO2005024040A2 TARGET AND METHOD FOR INHIBITION OF BACTERIAL RNA POLYMERASE: MINIMIZED DERIVATIVES OF PEPTIDE ANTIBIOTIC MccJ25
03/17/2005WO2005024035A1 Coiled-coil fusion proteins comprising cell receptor domains
03/17/2005WO2005024034A1 Method of in planta transformation of plant
03/17/2005WO2005024033A2 Nucleotide sequences promoting the trans-membrane transport of nucleic acids
03/17/2005WO2005024032A2 Targeting adenoviral vectors to dendritic cells
03/17/2005WO2005024031A1 Co-expression vector for the membrane domains of virus envelope proteins and uses thereof
03/17/2005WO2005024030A1 Rodent expression systems utilising polyoma virus and epstein barr virus sequences
03/17/2005WO2005024029A2 Plants having modified growth characteristics and method for making the same
03/17/2005WO2005024028A1 Utilization of zpt2-3 zinc finger type transcriptional factor in constructing plant with enhanced resistance to dryness
03/17/2005WO2005024026A1 Recombinant duffy antigens, fusions thereof, and use for detection of antibodies
03/17/2005WO2005024023A1 Brain tumor marker and method of diagnosing brain tumor
03/17/2005WO2005024022A1 Tick engorgement factor proteins
03/17/2005WO2005024020A1 Method of screening carcinogenecity of chemical
03/17/2005WO2005024019A1 Inducible bacterial expression system utilising sspa promoter from salmonella
03/17/2005WO2005024018A1 Nucleic acid construct and process for producing the same
03/17/2005WO2005024017A1 Nucleic acid molecules associated with oil in plants
03/17/2005WO2005024016A1 Mutant hsv vector useful in treating human glioma
03/17/2005WO2005024015A1 Expression vector
03/17/2005WO2005024012A1 Increased expression of a modified polypeptide
03/17/2005WO2005024008A1 Method of making sucrose phosphorylase(sp) heat-stable
03/17/2005WO2005024007A1 Use of pks 13 protein coding for condensase of mycolic acids of mycobacteria and related strains as an antibiotics target
03/17/2005WO2005024004A1 Method of differentiating mesenchymal stem cell into liver cell and artificial human liver cell
03/17/2005WO2005024003A1 Development of an anionic sensor for living cells : application to the human glycine receptor
03/17/2005WO2005024002A1 Recombinant production of antimicrobial agents
03/17/2005WO2005023998A1 Construction of new xylose utilizing saccharomyces cerevisiae strain
03/17/2005WO2005023997A1 Novel microorganism and method of treating organic solid matters with the use of the microorganism
03/17/2005WO2005023996A2 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-β PROTEINS (TGF-βs) IN CELLS
03/17/2005WO2005023995A2 Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry
03/17/2005WO2005023994A2 Modified oligonucleotides for telomerase inhibition
03/17/2005WO2005023991A2 Small hairpin rna libraries
03/17/2005WO2005023990A2 Trans-splicing mediated photodynamic therapy
03/17/2005WO2005023986A2 Microrna as ligands and target molecules
03/17/2005WO2005023979A2 Isolated s. mansoni nucleic acid molecules and uses thereof
03/17/2005WO2005023872A1 Antibodies against interleukin-1 receptor and uses thereof
03/17/2005WO2005023870A1 ANTIBODY RECOGNIZING TGF-β ACTIVATION CONTROLLING REGION SECTION
03/17/2005WO2005023868A1 Serine protease and polynucleotides which encode the serine protease
03/17/2005WO2005023865A2 Antibody-producing cell lines expressing activation-induced-cytidine-deaminase and a dominant negative allele of a mismatch repair gene
03/17/2005WO2005023858A1 Protein complexes associated with app-processing
03/17/2005WO2005023854A2 Modified 6-phosphofructo-1-kinase of the fungus aspergillus niger
03/17/2005WO2005023853A1 Protease-resistant seb variant and vaccine containing the same
03/17/2005WO2005023847A1 COMPOSITION FOR PROTECTING PROTEINS DEGRADATION COMPRISING SMALL HEAT SHOCK PROTEINS (sHSPs) AND METHOD OF TWO-DIMENSIONAL GEL ELECTROPHORESIS USING THE sHSPs
03/17/2005WO2005023837A2 Ebola peptides and immunogenic compositions containing same
03/17/2005WO2005023833A2 Treatment of neurodegenerative diseases
03/17/2005WO2005023829A1 Metal complex type nucleic acid
03/17/2005WO2005023313A1 Lentivirus vector-based approaches for generating an immune response to hiv humans
03/17/2005WO2005023312A2 Methods for transfecting cells using dna minor groove binding agents
03/17/2005WO2005023297A1 Composition for the prophylaxis/treatment of hbv infections and hbv-mediated diseases
03/17/2005WO2005023296A1 Treatment of rheumatic diseases
03/17/2005WO2005023292A1 Methods of treating restenosis
03/17/2005WO2005023205A2 Compositions and methods for yersinia pestis treatment
03/17/2005WO2005023186A2 Methods of identifying agents that inhibit the growth of cancer cells
03/17/2005WO2005023180A2 Method for detecting cancer cells and monitoring cancer therapy
03/17/2005WO2005023083A2 Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
03/17/2005WO2005014814A3 5’-and 3’-capped aptamers and uses therefor
03/17/2005WO2005003364A3 Stable integrands
03/17/2005WO2005003310A3 Glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate mutase promoters for gene expression in oleaginous yeast
03/17/2005WO2005002643A3 Method and products for delivering biological molecules to cells using multicomponent nanostructures
1 ... 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 ... 4023